Laser Speckle Contrast Imaging

Investigating clinically novel LSCI technology

Our group investigates the application of the clinically novel laser speckle contrast imaging. This technology helps surgeons assess tissue perfusion without the use of contrast dye, that is required with indocyanine green fluorescence. (Nwaiwu et al., 2023)

We have shown that subjecdtive interpretation of LSCI is equivalent to ICG in left-sided colorectal resections.(Skinner et al., 2024), and that objective quantification of LSCI is equivalent to quantification of ICG in pre-clinical porcine model. (Skinner et al., 2024)

References

2024

  1. Dis Colon Rectum
    Clinical Utility of Laser Speckle Contrast Imaging and Real-Time Quantification of Bowel Perfusion in Minimally Invasive Left-Sided Colorectal Resections
    G. Skinner, Y. Liu, A. Harzman, and 8 more authors
    Diseases of the Colon & Rectum, 2024
  2. Surg. Endosc.
    Dye-less Quantification of Tissue Perfusion by Laser Speckle Contrast Imaging is Equivalent to Quantified Indocyanine Green in a Porcine Model
    G. Skinner, M. Marois, J. Oberlin, and 3 more authors
    Surgical Endoscopy (Accepted), 2024

2023

  1. JOGS
    Real-time First-In-Human Comparison of Laser Speckle Contrast Imaging and ICG in Minimally Invasive Colorectal & Bariatric Surgery
    Chibueze A. Nwaiwu, Christopher J. McCulloh, Garrett Skinner, and 4 more authors
    Journal of Gastrointestinal Surgery, 2023